Octant is engineering a new generation of drug discovery.

Octant is developing a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells, paving the way for a new modality for drug discovery.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2017

• Founders

  • Sri Kosuri
  • Ramsey Homsany

  LUX Partners

  • Adam Goulburn

• Latest Tweets

  • We’ve really enjoyed working with Mark Murcko. We did a brief Q&A with him to talk about what attracted him to Octa… https://t.co/ezeUDVgy5r@OctantBio - 03:24 PM Oct 14th
  • We’re thrilled to announce Mark Murcko’s work with us on the Board of Directors and as a senior advisor. Official P… https://t.co/ZwCpucEtyj@OctantBio - 12:04 PM Oct 14th
  • Octant's website got a major upgrade! Check it out: https://t.co/MF9oRU5bA3@OctantBio - 04:59 PM Sep 22nd